Abstract
Recent advances in colorimetric biosensing have led to rapid methods for target detection, potentially leading to applications on-site, at the point-of-need. This review focuses on one such platform, the G-quadruplex-hemin based DNAzymes, which exhibit peroxidase- like activity. Since their discovery in the late 1990s, various approaches have been adopted in applying the unique catalytic properties of these DNAzymes to detecting nucleic acids, proteins, metal ions and other ligands, through the oxidation of substrate pre-cursors into colored products. G-quadruplex based DNAzymes act as modular units of G-rich DNA sequences, and hence can be synthesized cheaply and conveniently using routine oligonucleotide synthesis. Herein, we discuss the various strategies that have been developed to exploit this class of DNAzymes as candidate probes for optical detection and sensing, for a variety of chemical and biological targets.
Keywords: Biosensing, G-quadruplex, DNAzyme, Colorimeteric/Visual detection and sensing, Chemical biology, DNAzymes, nonimmunogenic, buffer conditions, guanine bases, eukaryotic
Current Pharmaceutical Design
Title:G-Quadruplex Based Probes for Visual Detection and Sensing
Volume: 18 Issue: 14
Author(s): J. L. Neo, K. Kamaladasan and M. Uttamchandani
Affiliation:
Keywords: Biosensing, G-quadruplex, DNAzyme, Colorimeteric/Visual detection and sensing, Chemical biology, DNAzymes, nonimmunogenic, buffer conditions, guanine bases, eukaryotic
Abstract: Recent advances in colorimetric biosensing have led to rapid methods for target detection, potentially leading to applications on-site, at the point-of-need. This review focuses on one such platform, the G-quadruplex-hemin based DNAzymes, which exhibit peroxidase- like activity. Since their discovery in the late 1990s, various approaches have been adopted in applying the unique catalytic properties of these DNAzymes to detecting nucleic acids, proteins, metal ions and other ligands, through the oxidation of substrate pre-cursors into colored products. G-quadruplex based DNAzymes act as modular units of G-rich DNA sequences, and hence can be synthesized cheaply and conveniently using routine oligonucleotide synthesis. Herein, we discuss the various strategies that have been developed to exploit this class of DNAzymes as candidate probes for optical detection and sensing, for a variety of chemical and biological targets.
Export Options
About this article
Cite this article as:
L. Neo J., Kamaladasan K. and Uttamchandani M., G-Quadruplex Based Probes for Visual Detection and Sensing, Current Pharmaceutical Design 2012; 18 (14) . https://dx.doi.org/10.2174/138161212799958341
DOI https://dx.doi.org/10.2174/138161212799958341 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets Osteoclast Apoptosis in Rheumatic Diseases Characterized by a High Level of Bone Resorption (Osteoporosis, Rheumatoid Arthritis, Myeloma and Pagets Disease of Bone)
Current Rheumatology Reviews MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
Current Pharmaceutical Biotechnology From TGF-β to Cancer Therapy
Current Drug Targets Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Current Medicinal Chemistry Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma
Current Radiopharmaceuticals Current Developments in the Therapeutic Potential of S-Nitrosoglutathione, an Endogenous NO-Donor Molecule
Current Pharmaceutical Biotechnology Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells
Current Drug Targets A Review of Cationic Arylfurans and Their Isosteres: Synthesis and Biological Importance
Current Organic Chemistry Glycolipid Stimulators for NKT Cells Bearing Invariant Vα19-Jα33 TCR α Chains
Mini-Reviews in Medicinal Chemistry Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Radiosensitizing Potential of Epigenetic Anticancer Drugs
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease
Current Medicinal Chemistry The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review
Current HIV Research TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Pancreatic Neoplasms and Autophagy
Current Drug Targets Associating Paracrine Communication to Regenerative Medicine: Search Strategies & Major Trends in Scientific and Patent Production
Recent Patents on Regenerative Medicine Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation
Anti-Cancer Agents in Medicinal Chemistry Subject Index to Volume 4
Current Pharmaceutical Biotechnology Kit: Molecule of Interest for the Diagnosis and Treatment of Mastocytosis and other Neoplastic Disorders
Current Cancer Drug Targets